HIV and antiretroviral therapy in the brain: neuronal injury and repair
about
Clinical factors related to brain structure in HIV: the CHARTER studyHuman immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neuronsEvidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapyNatural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaquesMagnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuseThe cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersNeurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapyCommon transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple SclerosisRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersHIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial HyperpolarizationInfectious Diseases of the Nervous System and Their Impact in Developing CountriesMechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersSynaptic Plasticity and Neurological Disorders in Neurotropic Viral InfectionsHIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorderMorphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesDisruption of neuronal CXCR4 function by opioids: preliminary evidence of ferritin heavy chain as a potential etiological agent in neuroAIDSProgression of temporal processing deficits in the HIV-1 transgenic ratHIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens.Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDSPharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations.HIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons.Review of functional MRI in HIV: effects of aging and medication.MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier.IFNβ Protects Neurons from Damage in a Murine Model of HIV-1 Associated Brain InjuryGene expression patterns associated with neurological disease in human HIV infectionHippocampal Neuronal Loss in Infant Macaques Orally Infected with Virulent Simian Immunodeficiency Virus (SIV).Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system.Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients.Neurocognitive effects of HIV, hepatitis C, and substance use historyVorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder.Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.Time-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive DisordersPathogenesis of HIV in the central nervous systemNeurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transportHIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment.HIV-associated deficits in action (verb) generation may reflect astrocytosis.Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.
P2860
Q24603224-D9B536D3-17A3-46F6-8021-3F50659035B7Q24628614-96E52C78-0C1E-4923-86D3-3495606526BCQ24631692-3360B3B1-B4A8-4694-9738-56E7F474C782Q24647731-36D3D4D8-6EE0-43CC-AE31-9913106F0FE1Q26746336-E005C4F4-8AA9-4A56-8884-AEBEDC6FA140Q26777952-7E937D66-6118-41B3-A402-5D529AF7AA1AQ27000422-4D96D2FA-A8E9-4C4E-9108-24C69087770AQ27007041-8CC818A4-E3F8-4383-8687-5DFDF9CF9960Q27025573-275058E5-6743-4A0D-9B2B-8B750E0D9602Q27487322-5A425CA8-A7E5-4D84-9D65-460902A1BEB4Q27487936-61894D32-14A4-4809-BDC3-D1167AF96615Q28082139-82842AF3-E6D1-492C-81A2-9A041DC532F6Q28088477-8345FAC5-DE05-48CF-B647-9C41F8E4DF22Q28394040-84B08963-8F8E-4961-AA42-2DB250FA6C89Q28539889-A7BA41AF-0BED-4E2F-BC41-20B628755E1AQ28750204-3FEED397-122C-4119-8258-9304BEBA0FDFQ30374656-738D68D3-C1E1-4406-8C1B-B05BB1693E49Q30397434-AF930D21-B420-4C4F-B5AF-9C7F5641C84FQ30399828-CDB16DDF-9B6A-4639-9236-46BBFCDCCB05Q30569766-A6ABE722-44BE-462A-A471-5D8B1EC93517Q30579142-3994B910-521F-45E6-B742-35FC7326087FQ30603781-4B85B95A-C25C-4FB3-B521-6694C7F56ED7Q30638542-5CBD909B-27ED-4C1A-98F5-A3319D65AB94Q30738175-B357ABD6-E55D-4EAC-B136-1C1427BE5DD6Q31135624-FC0CFB87-E116-46A2-B0DE-4187A82FAAC2Q33455125-BF27B1C6-EA4C-44DE-89CC-F468ECFC870FQ33582709-55B0579E-BF3E-4491-AB96-DFE11788FDAFQ33605737-0C9DFF1A-72CB-4266-B143-6708B443F168Q33607923-1DFD5CE5-211F-4EDD-A671-790DD015F5F3Q33610280-0021E0F0-7275-4370-8131-A03E0618CF93Q33640874-46434898-F41D-4796-93B0-48C5BA3804E6Q33652957-D4F351BB-094C-470E-A9C7-2E39D866D790Q33694166-7C55D03C-D9D6-4BF6-B76D-AB9B7393374DQ33700996-59FE8B4B-193D-433E-8536-01AFB387D515Q33734695-330BAD09-A47E-4726-A325-43EF16C8D5DDQ33781978-9A2DE98C-45AF-4352-8AA9-87DF1FAA922FQ33870898-BC34C4C3-BD34-42D2-9758-5786A24E511FQ33882450-4AD66535-5D76-41D9-8AD8-D03CADCC7CEAQ33884659-27E4A07F-8D3D-4037-A836-52D38A7B93ECQ33888584-948BF354-E32A-40AC-8DD4-8DA29ABB1758
P2860
HIV and antiretroviral therapy in the brain: neuronal injury and repair
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@ast
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@en
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@nl
type
label
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@ast
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@en
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@nl
prefLabel
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@ast
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@en
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@nl
P2860
P3181
P356
P1476
HIV and antiretroviral therapy in the brain: neuronal injury and repair
@en
P2093
Dianne Langford
P2860
P2888
P3181
P356
10.1038/NRN2040
P407
P577
2007-01-01T00:00:00Z
P5875
P6179
1046922687